Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis | 19 | 2024 | 279 | 6.370 |
Why?
|
| Pain | 10 | 2024 | 327 | 2.640 |
Why?
|
| Arthralgia | 5 | 2019 | 95 | 2.640 |
Why?
|
| Hyperalgesia | 6 | 2024 | 44 | 1.950 |
Why?
|
| Nociceptors | 5 | 2019 | 18 | 1.860 |
Why?
|
| Animals | 32 | 2024 | 3287 | 1.830 |
Why?
|
| Arthritis, Experimental | 5 | 2018 | 49 | 1.810 |
Why?
|
| Osteoarthritis, Knee | 6 | 2019 | 295 | 1.800 |
Why?
|
| Disease Models, Animal | 17 | 2024 | 517 | 1.500 |
Why?
|
| Mice | 20 | 2024 | 1236 | 1.420 |
Why?
|
| Neurons | 3 | 2017 | 272 | 1.320 |
Why?
|
| Nerve Growth Factor | 3 | 2024 | 38 | 1.270 |
Why?
|
| Knee Joint | 4 | 2024 | 572 | 1.260 |
Why?
|
| Ganglia, Spinal | 7 | 2024 | 52 | 1.210 |
Why?
|
| Cartilage, Articular | 6 | 2018 | 266 | 1.160 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 176 | 1.030 |
Why?
|
| Chemokine CCL2 | 5 | 2018 | 21 | 0.960 |
Why?
|
| Macrophages | 2 | 2024 | 98 | 0.950 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2014 | 55 | 0.930 |
Why?
|
| Microscopy | 1 | 2024 | 10 | 0.890 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 360 | 0.880 |
Why?
|
| Peptides | 3 | 2014 | 89 | 0.880 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2024 | 158 | 0.830 |
Why?
|
| Neuroimmunomodulation | 2 | 2019 | 7 | 0.790 |
Why?
|
| Nociception | 4 | 2019 | 10 | 0.780 |
Why?
|
| Behavior, Animal | 2 | 2024 | 47 | 0.750 |
Why?
|
| Chronic Pain | 4 | 2020 | 128 | 0.720 |
Why?
|
| Tissue Engineering | 2 | 2011 | 25 | 0.690 |
Why?
|
| Calcium | 3 | 2018 | 358 | 0.660 |
Why?
|
| Immunity, Innate | 2 | 2019 | 54 | 0.660 |
Why?
|
| Receptors, CCR2 | 3 | 2017 | 9 | 0.650 |
Why?
|
| Synovitis | 1 | 2019 | 20 | 0.630 |
Why?
|
| Toll-Like Receptors | 1 | 2019 | 17 | 0.630 |
Why?
|
| Pain Management | 2 | 2018 | 126 | 0.630 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 56 | 0.620 |
Why?
|
| Antibodies, Monoclonal | 2 | 2017 | 166 | 0.620 |
Why?
|
| Aggrecans | 2 | 2018 | 48 | 0.590 |
Why?
|
| ADAM Proteins | 2 | 2015 | 37 | 0.580 |
Why?
|
| Cytokines | 3 | 2019 | 213 | 0.580 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2018 | 33 | 0.560 |
Why?
|
| Cannabinoids | 1 | 2017 | 3 | 0.550 |
Why?
|
| Phytotherapy | 1 | 2017 | 11 | 0.550 |
Why?
|
| Cannabis | 1 | 2017 | 10 | 0.540 |
Why?
|
| Clozapine | 1 | 2017 | 5 | 0.540 |
Why?
|
| Neural Inhibition | 1 | 2017 | 8 | 0.540 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2017 | 17 | 0.520 |
Why?
|
| Male | 13 | 2024 | 12629 | 0.480 |
Why?
|
| Stifle | 1 | 2015 | 8 | 0.480 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 15 | 0.470 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 26 | 0.470 |
Why?
|
| Humans | 20 | 2020 | 23331 | 0.460 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2011 | 12 | 0.450 |
Why?
|
| Tissue Scaffolds | 2 | 2011 | 22 | 0.440 |
Why?
|
| Joints | 1 | 2014 | 67 | 0.420 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 7 | 0.410 |
Why?
|
| Protease Inhibitors | 1 | 2013 | 6 | 0.410 |
Why?
|
| Mice, Knockout | 5 | 2018 | 279 | 0.400 |
Why?
|
| Orthopedic Procedures | 1 | 2014 | 227 | 0.370 |
Why?
|
| Drug Carriers | 1 | 2011 | 5 | 0.360 |
Why?
|
| Blood Coagulation | 3 | 2006 | 21 | 0.360 |
Why?
|
| Heparin | 2 | 2010 | 23 | 0.360 |
Why?
|
| Chondroitin Sulfates | 1 | 2010 | 4 | 0.340 |
Why?
|
| Chondrogenesis | 1 | 2010 | 24 | 0.330 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 28 | 0.330 |
Why?
|
| Plasma | 2 | 2006 | 13 | 0.300 |
Why?
|
| Cells, Cultured | 4 | 2015 | 481 | 0.300 |
Why?
|
| Menisci, Tibial | 3 | 2017 | 91 | 0.290 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2017 | 53 | 0.270 |
Why?
|
| ADAMTS5 Protein | 2 | 2018 | 17 | 0.260 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2006 | 39 | 0.240 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 338 | 0.230 |
Why?
|
| Models, Theoretical | 3 | 2020 | 79 | 0.230 |
Why?
|
| Female | 6 | 2024 | 13124 | 0.230 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 197 | 0.220 |
Why?
|
| Signal Transduction | 2 | 2019 | 403 | 0.220 |
Why?
|
| Synovial Membrane | 2 | 2017 | 48 | 0.220 |
Why?
|
| Hydrogels | 3 | 2014 | 7 | 0.200 |
Why?
|
| Cattle | 3 | 2014 | 114 | 0.200 |
Why?
|
| Chondrocytes | 2 | 2014 | 97 | 0.190 |
Why?
|
| Analgesics | 2 | 2020 | 78 | 0.190 |
Why?
|
| Radiography | 2 | 2014 | 536 | 0.170 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 51 | 0.170 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2020 | 8 | 0.170 |
Why?
|
| Musculoskeletal Pain | 1 | 2020 | 19 | 0.160 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2019 | 5 | 0.160 |
Why?
|
| Spinal Cord Dorsal Horn | 1 | 2019 | 7 | 0.160 |
Why?
|
| Nerve Growth Factors | 1 | 2020 | 32 | 0.160 |
Why?
|
| Alarmins | 1 | 2019 | 2 | 0.160 |
Why?
|
| Biomarkers | 2 | 2019 | 487 | 0.160 |
Why?
|
| Rats | 2 | 2018 | 625 | 0.140 |
Why?
|
| ADAMTS4 Protein | 1 | 2018 | 15 | 0.140 |
Why?
|
| Matrix Metalloproteinases | 1 | 2018 | 18 | 0.140 |
Why?
|
| Ganglion Cysts | 1 | 2018 | 6 | 0.140 |
Why?
|
| Random Allocation | 2 | 2016 | 105 | 0.140 |
Why?
|
| Central Nervous System Sensitization | 1 | 2017 | 3 | 0.140 |
Why?
|
| TRPC Cation Channels | 1 | 2017 | 4 | 0.140 |
Why?
|
| Albuminuria | 1 | 2017 | 7 | 0.140 |
Why?
|
| Dronabinol | 1 | 2017 | 1 | 0.140 |
Why?
|
| Cannabidiol | 1 | 2017 | 3 | 0.140 |
Why?
|
| Receptors, CCR7 | 1 | 2017 | 7 | 0.140 |
Why?
|
| Disease Progression | 1 | 2019 | 525 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 312 | 0.130 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2017 | 6 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 23 | 0.130 |
Why?
|
| Catalysis | 3 | 2013 | 16 | 0.130 |
Why?
|
| Chemokines, CC | 1 | 2017 | 3 | 0.130 |
Why?
|
| Patch-Clamp Techniques | 1 | 2017 | 97 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2017 | 69 | 0.130 |
Why?
|
| Osteonecrosis | 1 | 2017 | 13 | 0.130 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 2 | 2014 | 2 | 0.130 |
Why?
|
| Drug Design | 2 | 2014 | 21 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 29 | 0.130 |
Why?
|
| Chemokine CX3CL1 | 1 | 2016 | 2 | 0.130 |
Why?
|
| Spinal Cord | 1 | 2017 | 74 | 0.130 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 569 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 84 | 0.120 |
Why?
|
| Pain Measurement | 1 | 2018 | 418 | 0.120 |
Why?
|
| Calgranulin A | 1 | 2015 | 5 | 0.120 |
Why?
|
| alpha-Macroglobulins | 1 | 2015 | 12 | 0.120 |
Why?
|
| Adsorption | 2 | 2014 | 5 | 0.120 |
Why?
|
| Microglia | 1 | 2016 | 109 | 0.120 |
Why?
|
| Proprotein Convertases | 1 | 2015 | 8 | 0.120 |
Why?
|
| Serine Endopeptidases | 1 | 2015 | 14 | 0.120 |
Why?
|
| Tibial Meniscus Injuries | 1 | 2015 | 46 | 0.110 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2014 | 2 | 0.110 |
Why?
|
| Delayed-Action Preparations | 1 | 2014 | 28 | 0.110 |
Why?
|
| Horses | 1 | 2014 | 6 | 0.110 |
Why?
|
| Blood Pressure | 1 | 2015 | 169 | 0.110 |
Why?
|
| Dogs | 1 | 2014 | 147 | 0.110 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 17 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 34 | 0.100 |
Why?
|
| Biomechanical Phenomena | 1 | 2014 | 524 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2012 | 285 | 0.090 |
Why?
|
| Biotinylation | 1 | 2011 | 1 | 0.090 |
Why?
|
| Streptavidin | 1 | 2011 | 3 | 0.090 |
Why?
|
| Fluorometry | 1 | 2011 | 5 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2011 | 7 | 0.090 |
Why?
|
| Glycosaminoglycans | 1 | 2011 | 18 | 0.090 |
Why?
|
| Solubility | 1 | 2011 | 25 | 0.090 |
Why?
|
| Protein Conformation | 1 | 2011 | 66 | 0.090 |
Why?
|
| DNA | 1 | 2011 | 97 | 0.090 |
Why?
|
| Stromal Cells | 1 | 2011 | 33 | 0.090 |
Why?
|
| Kinetics | 1 | 2011 | 179 | 0.090 |
Why?
|
| Proteoglycans | 1 | 2011 | 119 | 0.090 |
Why?
|
| Heparitin Sulfate | 1 | 2010 | 3 | 0.090 |
Why?
|
| Polysaccharide-Lyases | 1 | 2010 | 4 | 0.090 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 2010 | 3 | 0.090 |
Why?
|
| Regeneration | 1 | 2010 | 14 | 0.080 |
Why?
|
| Models, Animal | 1 | 2010 | 100 | 0.080 |
Why?
|
| Injections, Intra-Articular | 1 | 2010 | 56 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 880 | 0.080 |
Why?
|
| Dexamethasone | 1 | 2010 | 34 | 0.080 |
Why?
|
| Rabbits | 1 | 2010 | 168 | 0.080 |
Why?
|
| Arthroscopy | 1 | 2014 | 549 | 0.080 |
Why?
|
| Surface Properties | 2 | 2006 | 125 | 0.070 |
Why?
|
| Protein Engineering | 1 | 2008 | 6 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 46 | 0.070 |
Why?
|
| Models, Biological | 2 | 2005 | 306 | 0.060 |
Why?
|
| Mutation | 2 | 2020 | 328 | 0.060 |
Why?
|
| Silanes | 1 | 2006 | 1 | 0.060 |
Why?
|
| Microscopy, Atomic Force | 1 | 2006 | 4 | 0.060 |
Why?
|
| Factor XII | 1 | 2005 | 1 | 0.060 |
Why?
|
| Prothrombin | 1 | 2005 | 4 | 0.060 |
Why?
|
| Coagulants | 1 | 2005 | 11 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2005 | 83 | 0.060 |
Why?
|
| Collagen Type V | 1 | 2020 | 3 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 452 | 0.040 |
Why?
|
| Skin | 1 | 2020 | 119 | 0.040 |
Why?
|
| Neurons, Afferent | 1 | 2018 | 6 | 0.040 |
Why?
|
| Sesquiterpenes, Guaiane | 1 | 2017 | 1 | 0.030 |
Why?
|
| Piperidines | 1 | 2017 | 12 | 0.030 |
Why?
|
| Indoles | 1 | 2017 | 32 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 88 | 0.030 |
Why?
|
| Podocytes | 1 | 2017 | 37 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2016 | 33 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 132 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 167 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 178 | 0.030 |
Why?
|
| Cricetinae | 1 | 2015 | 34 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 61 | 0.030 |
Why?
|
| Epitopes | 1 | 2015 | 39 | 0.030 |
Why?
|
| Crystallization | 1 | 2014 | 3 | 0.030 |
Why?
|
| Diffusion | 1 | 2014 | 24 | 0.030 |
Why?
|
| Cell Survival | 1 | 2014 | 102 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 172 | 0.030 |
Why?
|
| Hypertension | 1 | 2015 | 162 | 0.030 |
Why?
|
| Materials Testing | 1 | 2014 | 113 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2014 | 168 | 0.030 |
Why?
|
| Brain | 1 | 2017 | 1200 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2008 | 9 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 29 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 69 | 0.020 |
Why?
|
| Protein Binding | 1 | 2008 | 115 | 0.020 |
Why?
|
| Adult | 1 | 2017 | 7070 | 0.020 |
Why?
|
| Factor XIIa | 1 | 2005 | 1 | 0.010 |
Why?
|
| Titrimetry | 1 | 2005 | 3 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2005 | 35 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 2005 | 12 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 7552 | 0.010 |
Why?
|
| Thrombin | 1 | 2005 | 14 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 8055 | 0.010 |
Why?
|
| Blood Coagulation Factors | 1 | 2005 | 19 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 113 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 1289 | 0.010 |
Why?
|